AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

• Main Authors: Dunne, P.D., McArt, D.G., Blayney, J.K., Kalimutho, M., Greer, S., Wang, T., Srivastava, S., Ong, C.W., Arthur, K., Loughrey, M., Redmond, K., Longley, D.B., Salto-Tellez, M., Johnston, P.G., Van Schaeybroeck, S.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: 2014
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/116236
• Institution: National University of Singapore

10.1158/1078-0432.CCR-13-1354